RSS-Feed abonnieren
DOI: 10.1055/s-0029-1217700
Domino Alkylation-Cyclization Reaction of Propargyl Bromides with Thioureas/Thiopyrimidinones: A New Facile Synthesis of 2-Aminothiazoles and 5H-Thiazolo[3,2-a]pyrimidin-5-ones
Publikationsverlauf
Publikationsdatum:
15. Juli 2009 (online)
Abstract
A new synthesis of 2-aminothiazoles and 5H-thiazolo[3,2-a]pyrimidin-5-ones was developed as a domino alkylation-cyclization reaction of propargyl bromides with thioureas and thiopyrimidinones, respectively. Domino reactions were performed under microwave irradiation leading to desired compounds in a few minutes and high yields.
Key words
domino reaction - 2-aminothiazole - thiazolopyrimidinone - microwave synthesis - antiviral agents
-
1a
Hargrave KD.Hess FK.Oliver JT. J. Med. Chem. 1983, 26: 1158 -
1b
Patt WC.Hamilton HW.Taylor MD.Ryan MD.Ryan MJ.Taylor DJJ.Connoly CJC.Doherty AM.Klutchko SR.Sircar I.Steinbaugh BA.Batly BL.Painchaud CA.Rapundalo ST.Michniewicz BM.Olson SCJ. J. Med. Chem. 1992, 35: 2562 -
1c
Haviv F.Ratajczyk JD.DeNet RW.Kedesky FA.Walters RL.Schmidt SP.Holms JH.Young PR.Carter GW. J. Med. Chem. 1988, 31: 1719 -
1d
Bell FW.Cantrell AS.Hoberg M.Jaskunas SR.Johansson NG.Jodon CL.Kinnik MD.Lind P.Morin JM.Zhang H.Zhou X.-X. J. Med. Chem. 1995, 38: 4929 - 2
Hantzsch AR.Weber JH. Ber. Dtsch. Chem. Ges. 1887, 20: 3118 -
3a
Zav’yalov SI.Dorofeeva OV.Rumyantseva EE.Kulikova LB.Ezhova GI.Kravchenko NE.Zavozin AG. Pharm. Chem. J. 2001, 35: 96 -
3b
Aoyama T.Murata S.Arai I.Araki N.Takido T.Suzuki Y.Kodomari M. Tetrahedron 2006, 62: 3201 -
3c
Kodomari M.Aoyama T.Suzuki Y. Tetrahedron Lett. 2002, 43: 1717 -
3d
Astle MJ.Pierce JB. J. Org. Chem. 1955, 20: 178 -
3e
Wipf P.Venkatraman S. J. Org. Chem. 1996, 61: 8004 -
3f
Miyamoto K.Nishi Y.Ochiai M. Angew. Chem. Int. Ed. 2005, 44: 6896 -
4a
Doria G.Passarotti C.Sala R.Magrini R.Sberze P.Tibolla M.Cesarini R.Castello R.Toti D. Farmaco 1985, 40: 885 -
4b
Bonacorso HG.Lourega RV.Wastowski AD.Flores AFC.Zanatta N.Martins MAP. Tetrahedron Lett. 2002, 43: 9315 -
5a
Manetti F.Esté JA.Clotet-Codina I.Armand-Ugón M.Maga G.Crespan E.Cancio R.Mugnaini C.Bernardini C.Togninelli A.Carmi C.Alongi M.Petricci E.Massa S.Corelli F.Botta M. J. Med. Chem. 2005, 48: 8000 -
5b
Mugnaini C.Alongi M.Togninelli A.Gevariya H.Brizzi A.Manetti F.Bernardini C.Angeli L.Tafi A.Bellucci L.Corelli F.Massa S.Maga G.Samuele A.Facchini M.Clotet-Codina I.Armand-Ugón M.Esté JA.Botta M. J. Med. Chem. 2007, 50: 6580 - 6
Dai W.Petersen JL.Wang KK. Org. Lett. 2006, 8: 4665 - 8
Danel K.Pedersen EB.Nielsen C. J. Med. Chem. 1998, 41: 191 -
9a
Heravi MM.Kivanloo A.Rahimzadeh M.Bakavoli M.Ghassemzadeh M.Neumüller B. Tetrahedron Lett. 2005, 46: 1607 -
9b
Rodríguez-Franco MI.Dorronsoro I.Martínez A.Castro A. J. Heterocycl. Chem. 2001, 38: 435
References and Notes
Reaction of alkyne 7 with thiourea 8a was also carried out under the same reaction conditions but in the absence of K2CO3. No traces of aminothiazole 9g were detected in this case and only complex side products, whose characterization was difficult, were isolated.
10Synthesis of 2-Aminothiazoles 9a-i; General Procedure: Alkyne 3, 6 or 7 (1.0 mmol) and the appropriate thiourea 8a-c (1.0 mmol) were suspended in anhyd DMF (1.0 mL) in a 10 mL glass vial equipped with a small magnetic stirring bar. K2CO3 (1.0 mmol) was then added to this solution and the mixture was irradiated under microwave conditions at 130 ˚C (2 × 5 min), using an irradiation power of 300 W. Microwave irradiations were conducted using a CEM Discover Synthesis Unit (CEM Corp., Matthews, NC). The mixture was then poured into H2O (10 mL) and then extracted with EtOAc (2 × 10 mL). The combined organic phases were washed with brine, dried over Na2SO4, filtered and concentrated under reduced pressure. The crude products were purified by flash column chromatography (SiO2; hexanes-EtOAc, 1:1), to yield the 2-aminothiazoles 9a-i as tan-colored oils.
11Characterization of 13a: ¹H NMR (CDCl3): δ = 7.54 (s, 1 H, SCHCHCH3), 7.08-7.06 (m, 1 H, Ph), 6.75-6.71 (m, 2 H, Ph), 4.56-4.54 (m, 1 H, CH3CHPh), 2.34 (s, 3 H, NCCH 3), 1.94 (s, 3 H, CH 3), 1.58 (d, 3 H, CHCH 3). ¹³C NMR (CDCl3): δ = 162.61, 160.13, 159.36, 151.22, 128.20, 128.00, 124.85, 119.38, 117.84, 111.64, 34.27, 17.88, 13.47, 10.35. MS (ESI): m/z = 321 [M + H]+, 343 [M + Na]+. Characterization of 13b: ¹H NMR (CDCl3): δ = 7.08-7.04 (m, 1 H, Ph), 6.76-6.72 (m, 2 H, Ph), 6.27 (s, 1 H, SCHCHCH3), 4.54-4.49 (m, 1 H, CH3CHPh), 2.70 (s, 3 H, NCCH 3), 1.89 (s, 3 H, CH 3), 1.58 (d, 3 H, CHCH 3). ¹³C NMR (CDCl3): δ = 162.63, 162.24, 160.14, 146.41, 135.98, 128.09, 119.37, 112.86, 111.38, 105.68, 34.07, 18.56, 17.77, 10.23. MS (ESI): m/z = 321 [M + H]+, 343 [M + Na]+.
12Characterization of 14: ¹H
NMR (CDCl3): δ = 7.11-7.04
(m,
3 H, Ph), 6.81-6.72 (m, 4 H, Ph), 5.97
(s, 1 H, SCH), 4.53 (m, 1 H,
CH3CHPh), 4.50 (s, 2 H,
CH
2PhOMe), 3.71
(s,
3 H, OCH
3), 1.91
(s, 3 H, CH
3), 1.59
(d, J = 8.0
Hz,
3 H, CHCH
3). ¹³C
NMR (CDCl3): δ = 162.60, 161.85, 160.35,
158.61, 140.31, 130.62, 130.38, 129.99, 119.34, 114.38, 113.84,
111.77, 111.30, 106.19, 55.40, 37.06, 33.96, 17.80, 10.77. MS (ESI): m/z = 427 [M + H]+,
449 [M + Na]+.